HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Takayuki Nakagawa Selected Research

Liposomes (Liposome)

1/2021Pronociceptive Roles of Schwann Cell-Derived Galectin-3 in Taxane-Induced Peripheral Neuropathy.
1/2020Schwann cell-derived CXCL1 contributes to human immunodeficiency virus type 1 gp120-induced neuropathic pain by modulating macrophage infiltration in mice.
1/2017Colchicine alleviates acute postoperative pain but delays wound repair in mice: roles of neutrophils and macrophages.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Takayuki Nakagawa Research Topics

Disease

101Neoplasms (Cancer)
12/2024 - 10/2002
20Pain (Aches)
01/2021 - 10/2002
18Carcinoma (Carcinomatosis)
05/2024 - 04/2013
17Sensorineural Hearing Loss
01/2024 - 12/2006
16Melanoma (Melanoma, Malignant)
12/2024 - 07/2013
16Lung Neoplasms (Lung Cancer)
06/2020 - 03/2012
14Inflammation (Inflammations)
07/2023 - 05/2005
14Peripheral Nervous System Diseases (PNS Diseases)
01/2023 - 07/2012
12Neoplasm Metastasis (Metastasis)
12/2024 - 10/2003
11Wounds and Injuries (Trauma)
01/2023 - 02/2005
11Hypersensitivity (Allergy)
01/2023 - 07/2012
11Hyperalgesia
01/2023 - 10/2002
10Breast Neoplasms (Breast Cancer)
04/2022 - 04/2013
10Hearing Loss (Hearing Impairment)
10/2020 - 01/2004
8Infections
07/2023 - 07/2003
7Neuralgia (Stump Neuralgia)
07/2018 - 10/2002
7Noise-Induced Hearing Loss (Acoustic Trauma)
05/2014 - 02/2005
6Adenocarcinoma
01/2023 - 02/2012
6Ischemia
10/2021 - 10/2008
6Cold Hypersensitivity
12/2019 - 07/2012
5Hypoxia (Hypoxemia)
12/2024 - 03/2016
5Drug-Related Side Effects and Adverse Reactions
01/2023 - 01/2019
5Cystitis
01/2020 - 01/2013
5Carcinogenesis
12/2018 - 01/2012
4Respiratory Insufficiency (Respiratory Failure)
01/2023 - 01/2019
4Hemorrhage
04/2019 - 02/2007
4Sudden Hearing Loss (Sudden Deafness)
10/2016 - 08/2012
4Labyrinth Diseases
11/2014 - 03/2004
3Stomatitis
04/2024 - 11/2022
3Ganglion Cysts (Ganglion)
01/2024 - 06/2003
3COVID-19
07/2023 - 01/2022
3Necrosis
07/2023 - 11/2017
3Gliosis
02/2023 - 09/2010
3Rheumatoid Arthritis
01/2023 - 01/2021
3Squamous Cell Carcinoma of Head and Neck
12/2022 - 10/2006

Drug/Important Bio-Agent (IBA)

16Proteins (Proteins, Gene)FDA Link
05/2024 - 10/2006
14Tyrosine Kinase InhibitorsIBA
01/2017 - 01/2010
12Biomarkers (Surrogate Marker)IBA
12/2024 - 01/2013
12ErbB Receptors (EGF Receptor)IBA
01/2017 - 03/2012
10MicroRNAs (MicroRNA)IBA
06/2024 - 01/2012
10Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
02/2023 - 04/2009
10Oxaliplatin (Eloxatin)FDA LinkGeneric
02/2023 - 07/2012
9Messenger RNA (mRNA)IBA
06/2024 - 07/2003
9LigandsIBA
01/2023 - 10/2003
9Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2021 - 10/2009
9HydrogelsIBA
11/2014 - 04/2006
8CytokinesIBA
07/2023 - 09/2004
8Analgesics (Analgesic Drugs)IBA
01/2023 - 10/2002
8Phosphotransferases (Kinase)IBA
11/2022 - 10/2009
8CrizotinibIBA
01/2019 - 07/2012
8Gefitinib (Iressa)FDA Link
01/2015 - 03/2012
7Opioid Analgesics (Opioids)IBA
01/2023 - 01/2008
7Paclitaxel (Taxol)FDA LinkGeneric
01/2021 - 07/2012
7Morphine (MS Contin)FDA LinkGeneric
01/2019 - 02/2004
7Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2015 - 07/2012
7GelatinIBA
11/2014 - 10/2007
6RNA (Ribonucleic Acid)IBA
12/2024 - 12/2018
6PlatinumIBA
12/2019 - 07/2012
6Cisplatin (Platino)FDA LinkGeneric
10/2019 - 01/2004
6AnkyrinsIBA
01/2018 - 01/2016
5AntibodiesIBA
01/2024 - 10/2014
5Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
01/2023 - 04/2008
5Therapeutic UsesIBA
01/2023 - 03/2010
5DNA (Deoxyribonucleic Acid)IBA
01/2022 - 10/2017
5Formaldehyde (Formol)FDA Link
03/2021 - 01/2007
5Taxoids (Taxanes)IBA
01/2021 - 01/2017
5Insulin-Like Growth Factor I (IGF-1)IBA
10/2020 - 04/2006
5Insulin-Like PeptidesIBA
01/2019 - 10/2007
5Glutamic Acid (Glutamate)FDA Link
07/2013 - 01/2004
4Monoclonal AntibodiesIBA
01/2024 - 11/2020
4Neutralizing AntibodiesIBA
01/2023 - 09/2012
4Anti-Bacterial Agents (Antibiotics)IBA
11/2022 - 01/2020
4EnzymesIBA
04/2022 - 02/2005
4AntigensIBA
01/2021 - 10/2002
4Adrenal Cortex Hormones (Corticosteroids)IBA
10/2018 - 01/2013
4Adenosine Triphosphate (ATP)IBA
07/2018 - 10/2002
4Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric
02/2017 - 01/2013
4Reactive Oxygen Species (Oxygen Radicals)IBA
09/2014 - 09/2008
4Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
06/2014 - 10/2009
4Adrenergic Receptors (Adrenergic Receptor)IBA
01/2014 - 07/2008
4SteroidsIBA
01/2013 - 11/2010
3VaccinesIBA
10/2023 - 01/2021
3Tadalafil (Cialis)FDA Link
07/2023 - 01/2018
3ProdrugsIBA
07/2023 - 01/2022
3Interleukin-6 (Interleukin 6)IBA
01/2023 - 02/2010
3Infliximab (Remicade)FDA Link
01/2023 - 01/2021
3LipidsIBA
05/2022 - 05/2017
3Antiviral Agents (Antivirals)IBA
01/2022 - 07/2013
3taxaneIBA
01/2021 - 01/2018
3Liposomes (Liposome)IBA
01/2021 - 01/2017
3Clodronic Acid (Clodronate)IBA
01/2021 - 01/2017
3Fentanyl (Sublimaze)FDA LinkGeneric
01/2021 - 01/2019
3Telomerase (Telomerase Reverse Transcriptase)IBA
01/2021 - 05/2003

Therapy/Procedure

47Therapeutics
05/2024 - 03/2004
18Drug Therapy (Chemotherapy)
08/2023 - 01/2009
7Immunotherapy
06/2023 - 01/2017
7Ligation
11/2018 - 04/2004
5Transplantation
01/2015 - 03/2004
4Intravesical Administration
02/2017 - 01/2013
3Radiotherapy
08/2023 - 01/2015